-
Galena Shares Up 50% On Regulatory Pathway For Thrombosis Treatment
Wednesday, December 28, 2016 - 10:56am | 327Read More...Shares of Galena Biopharma Inc (NASDAQ: GALE), a nano-cap biopharmaceutical company that focuses on hematology and oncology therapeutics for the treatment of unmet medical needs, gained more than 20 percent ahead of Wednesday's market open. Galena is currently evaluating its GALE-401 therapy for...
